|
Video: What is a Stock Split?
|
|
Acceleron Pharma is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutics to treat diseases. Co.'s research focuses on natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta, or TGF-beta, protein superfamily. By combining Co.'s discovery and development capabilities, including its proprietary knowledge of the TGF-beta superfamily, and its internal protein engineering and manufacturing capabilities, Co. generates therapeutic candidates, all of which encompass potential mechanisms of action. Co. has focused and prioritized its research and development activities within pulmonary and hematology. According to our XLRN split history records, XLRN has had 0 splits. | |
|
XLRN (XLRN) has 0 splits in our XLRN split history database.
Looking at the XLRN split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into XLRN shares, starting with a $10,000 purchase of XLRN, presented on a split-history-adjusted basis factoring in the complete XLRN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/02/2014 |
|
End date: |
11/22/2021 |
|
Start price/share: |
$33.70 |
|
End price/share: |
$178.75 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
430.42% |
|
Average Annual Total Return: |
24.68% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$53,044.91 |
|
Years: |
7.56 |
|
|
|
|
|